Spago Nanomedical AB (7UX) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| [177Lu]Lu-Sn201 | Solid Tumor, Recurrent Solid Tumor, Locally Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer, Unresectable Solid Tumor | phase1AndPhase2 | Recruiting | A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer | Dec 06, 2023 | ― |
| Sn132d | Endometriosis | Phase II | Completed | Efficacy of SN132D in Patients With Suspected Endometriosis | Dec 07, 2022 | ― |
| Sn132d | Breast Cancer, Pancreas Cancer | Phase I | Completed | A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer | Aug 27, 2019 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| [177Lu]Lu-Sn201 | phase1AndPhase2 | Solid Tumor, Recurrent Solid Tumor, Locally Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer, Unresectable Solid Tumor | Recruiting | A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer | Dec 06, 2023 | ― |
| Sn132d | Phase II | Endometriosis | Completed | Efficacy of SN132D in Patients With Suspected Endometriosis | Dec 07, 2022 | ― |
| Sn132d | Phase I | Breast Cancer, Pancreas Cancer | Completed | A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer | Aug 27, 2019 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Spago Nanomedical AB (DE:7UX) have in its pipeline
Spago Nanomedical AB DE:7UX is currently developing the following drugs: [177Lu]Lu-Sn201, Sn132d. These drug candidates are in various stages of clinical development as the company works toward FDA approval.